|
|
|
|
||
Re: Could the applicable patients in the current Phase 3 Trial be added to a new trial.I think the FR-alpha high subgroup data from FORWARD I would support BTD at the FDA. Anna B. brushed aside the question, and they say they are focusing on designing the PIII; however I think they could and should apply for the designation. |
return to message board, top of board |